478 related articles for article (PubMed ID: 27582008)
1. Target DNA recognition and cleavage by a reconstituted Type I-G CRISPR-Cas immune effector complex.
Majumdar S; Ligon M; Skinner WC; Terns RM; Terns MP
Extremophiles; 2017 Jan; 21(1):95-107. PubMed ID: 27582008
[TBL] [Abstract][Full Text] [Related]
2. CRISPR RNA-guided DNA cleavage by reconstituted Type I-A immune effector complexes.
Majumdar S; Terns MP
Extremophiles; 2019 Jan; 23(1):19-33. PubMed ID: 30284045
[TBL] [Abstract][Full Text] [Related]
3. Three CRISPR-Cas immune effector complexes coexist in Pyrococcus furiosus.
Majumdar S; Zhao P; Pfister NT; Compton M; Olson S; Glover CV; Wells L; Graveley BR; Terns RM; Terns MP
RNA; 2015 Jun; 21(6):1147-58. PubMed ID: 25904135
[TBL] [Abstract][Full Text] [Related]
4. DNA targeting by the type I-G and type I-A CRISPR-Cas systems of Pyrococcus furiosus.
Elmore J; Deighan T; Westpheling J; Terns RM; Terns MP
Nucleic Acids Res; 2015 Dec; 43(21):10353-63. PubMed ID: 26519471
[TBL] [Abstract][Full Text] [Related]
5. Primed CRISPR DNA uptake in Pyrococcus furiosus.
Garrett S; Shiimori M; Watts EA; Clark L; Graveley BR; Terns MP
Nucleic Acids Res; 2020 Jun; 48(11):6120-6135. PubMed ID: 32421777
[TBL] [Abstract][Full Text] [Related]
6. The CRISPR-associated DNA-cleaving enzyme Cpf1 also processes precursor CRISPR RNA.
Fonfara I; Richter H; Bratovič M; Le Rhun A; Charpentier E
Nature; 2016 Apr; 532(7600):517-21. PubMed ID: 27096362
[TBL] [Abstract][Full Text] [Related]
7. The CRISPR-associated Csx1 protein of Pyrococcus furiosus is an adenosine-specific endoribonuclease.
Sheppard NF; Glover CV; Terns RM; Terns MP
RNA; 2016 Feb; 22(2):216-24. PubMed ID: 26647461
[TBL] [Abstract][Full Text] [Related]
8. Bipartite recognition of target RNAs activates DNA cleavage by the Type III-B CRISPR-Cas system.
Elmore JR; Sheppard NF; Ramia N; Deighan T; Li H; Terns RM; Terns MP
Genes Dev; 2016 Feb; 30(4):447-59. PubMed ID: 26848045
[TBL] [Abstract][Full Text] [Related]
9. The RNA- and DNA-targeting CRISPR-Cas immune systems of Pyrococcus furiosus.
Terns RM; Terns MP
Biochem Soc Trans; 2013 Dec; 41(6):1416-21. PubMed ID: 24256230
[TBL] [Abstract][Full Text] [Related]
10. A type III-B CRISPR-Cas effector complex mediating massive target DNA destruction.
Han W; Li Y; Deng L; Feng M; Peng W; Hallstrøm S; Zhang J; Peng N; Liang YX; White MF; She Q
Nucleic Acids Res; 2017 Feb; 45(4):1983-1993. PubMed ID: 27986854
[TBL] [Abstract][Full Text] [Related]
11. Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex.
Hale CR; Cocozaki A; Li H; Terns RM; Terns MP
Genes Dev; 2014 Nov; 28(21):2432-43. PubMed ID: 25367038
[TBL] [Abstract][Full Text] [Related]
12. Cas3 is a limiting factor for CRISPR-Cas immunity in Escherichia coli cells lacking H-NS.
Majsec K; Bolt EL; Ivančić-Baće I
BMC Microbiol; 2016 Mar; 16():28. PubMed ID: 26956996
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure of the CRISPR-Cas RNA silencing Cmr complex bound to a target analog.
Osawa T; Inanaga H; Sato C; Numata T
Mol Cell; 2015 May; 58(3):418-30. PubMed ID: 25921071
[TBL] [Abstract][Full Text] [Related]
14. Molecular insights into DNA interference by CRISPR-associated nuclease-helicase Cas3.
Gong B; Shin M; Sun J; Jung CH; Bolt EL; van der Oost J; Kim JS
Proc Natl Acad Sci U S A; 2014 Nov; 111(46):16359-64. PubMed ID: 25368186
[TBL] [Abstract][Full Text] [Related]
15. Genetic determinants of PAM-dependent DNA targeting and pre-crRNA processing in Sulfolobus islandicus.
Peng W; Li H; Hallstrøm S; Peng N; Liang YX; She Q
RNA Biol; 2013 May; 10(5):738-48. PubMed ID: 23392249
[TBL] [Abstract][Full Text] [Related]
16. Crystal Structures of Csm2 and Csm3 in the Type III-A CRISPR-Cas Effector Complex.
Takeshita D; Sato M; Inanaga H; Numata T
J Mol Biol; 2019 Feb; 431(4):748-763. PubMed ID: 30639408
[TBL] [Abstract][Full Text] [Related]
17. Fragmentation of the CRISPR-Cas Type I-B signature protein Cas8b.
Richter H; Rompf J; Wiegel J; Rau K; Randau L
Biochim Biophys Acta Gen Subj; 2017 Nov; 1861(11 Pt B):2993-3000. PubMed ID: 28238733
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the Cmr2-Cmr3 subcomplex in the CRISPR-Cas RNA silencing effector complex.
Osawa T; Inanaga H; Numata T
J Mol Biol; 2013 Oct; 425(20):3811-23. PubMed ID: 23583914
[TBL] [Abstract][Full Text] [Related]
19. Multiple mechanisms for CRISPR-Cas inhibition by anti-CRISPR proteins.
Bondy-Denomy J; Garcia B; Strum S; Du M; Rollins MF; Hidalgo-Reyes Y; Wiedenheft B; Maxwell KL; Davidson AR
Nature; 2015 Oct; 526(7571):136-9. PubMed ID: 26416740
[TBL] [Abstract][Full Text] [Related]
20. Cmr4 is the slicer in the RNA-targeting Cmr CRISPR complex.
Zhu X; Ye K
Nucleic Acids Res; 2015 Jan; 43(2):1257-67. PubMed ID: 25541196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
